Nav1.7
Description: sodium channel, voltage-gated, type IX, alpha Gene: Scn9a Synonyms: nav1.7, scn9a
SCN9A (also known as PN1; ETHA; NENA; FEB3B; NE-NA; GEFSP7; Nav1.7) encodes the tetrodotoxin sensitive channel Nav1.7, a voltage-gated sodium channel, type IX, alpha subunit which plays a significant role in nociception signaling. Nav1.7 regulates sensory neuron excitability and contributes to several sensory modalities. Mutations in SCN9A have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder.
http://www.ncbi.nlm.nih.gov/gene/6335 [1419]
Gene
Transcript
Ontology
Accession | Name | Definition | Evidence | |||||||
---|---|---|---|---|---|---|---|---|---|---|
GO:0001518 | voltage-gated sodium channel complex | A sodium channel in a cell membrane whose opening is governed by the membrane potential. | IDA | |||||||
GO:0016020 | membrane | Double layer of lipid molecules that encloses all cells, and, in eukaryotes, many organelles; may be a single or double lipid bilayer; also includes associated proteins. | IEA | |||||||
GO:0016021 | integral to membrane | Penetrating at least one phospholipid bilayer of a membrane. May also refer to the state of being buried in the bilayer with no exposure outside the bilayer. When used to describe a protein, indicates that all or part of the peptide sequence is embedded in the membrane. | IEA |
The nerve-growth-factor-induced increase in peak voltage geated sodium channel current density in strongly metastatic Mat-LyLu cell (model of rat prostate cancer) was suppressed by both the pan-trk antagonist K252a, and the protein kinase A inhibitor KT5720. Nerve-growth-factor did not affect the Nav1.7 mRNA level, but the total VGSC a-subunit protein level was upregulated. [215]
Tetrodotoxin
Nav1.7 is TTX sensitive (non selective) [1376]
Protein
Each α subunit - hence also Nav1.7 - is composed of four homologous domains (DI-DIV), with each domain consisting of six transmembrane segments (S1–S6), with S4 acting as a voltage-sensor and S5 and S6 lining the pore [815]. Structural modellings approach of Nav1.7 have identified an aromatic residue within the cytoplasm-proximal portion of each of the pore-lining S6 helices that were predicted to form a hydrophobic ring at the cytoplasmic end of the pore that stabilizes the channel’s pre-open state. This element is predicted to raise the energy barrier for the movement of S6, which is necessary to open the channel’s pore, thus stabilizing the closed or pre-open state of the channel [1419][1420].
NaV1.7 is uniformly distributed in the somata of in both large and small diameter DRG neurons and along the identified Aβ-fibres and C fibres, being expressed at high levels in nociceptive neurons. NaV1.7 is present peripherally within free nerve endings in the epidermis and centrally within superficial lamina of the dorsal horn in the spinal cord [850][1419].
NaV1.7 expression is detected in [1419], [847], [848]:
• Somatosensory and sympathetic ganglion
• Myenteric neurons
• Olfactory sensory neurons (OSNs)
• Visceral sensory neurons
• Smooth myocytes (in the plasmalemma) [1425]
Measurable NaV1.7 levels have not been detected in other regions of the CNS in humans but in rodent it has been detected in the hypothalamus and in the pituitary gland [1423].
NaV1.7 expression has also been detected within non-excitable cells, including: the adrenal glands (only in rodents) [1423] prostate and breast tumour cells, human erythroid progenitor cells, immune cells [1419] and in the strongly metastatic Dunning rat PCa Mat-LyLu cell line, VGSC/Nav1.7 a-subunit mRNA was upregulated over 1,000-fold, compared to the isogenic weakly metastatic AT-2 cells [835], [847], [848].
Activated MAPK to regulate the expression of Nav1.7 in diabetic neuropathy [1421] and in human neuromas [1422].
Primary erythromelalgia has been linked to mutations in SCN9A, the gene that encodes voltage-gated sodium channel NaV1.7 [851], [214].
Channelopathies
Mutations in Nav1.7 have been identified in patients several human disorders (for further information see Table 3 of [1422]):
* Anosmia [846]
* Inherited erythromelalgia (IEM) [1424]
* Paroxysmal extreme pain disorder (PEPD)[1424]
* Channelophaty-associated insensitivity to pain (CIP) [1424]
Functional voltage gated sodium channel expression is considered "necessary and sufficient" for potentiation of prostate cancer cell invasiveness [853] and it is also involved in the pain mechanisms of Parkinson Disease [1425].
Mouse models:
- Nav1.7 Conditional KO (burn injury) [1426]
- Nav1.7/Nav1.8 double KO [1427]
- Nav1.7/Nav1.8 double KO (infammatory pain) [1428]
- Nav1.7 null [1428]. This mutation in lethal in rodents but not in humans. The lethality of the Nav1.7 knockout mice is due to failure to feed, possibly resulting from dysfunctions of central, autonomic or enteric sensory neurons because of a distinct expression of Nav1.7 in rodent brain and in endocrine glands [1423].
Based on its biophysical properties, Nav1.7 is poised to amplify generator potentials in neurons expressing it, including nociceptors, and to act as a threshold channel for firing action potentials and setting the gain in pain-signaling neurons [1419]. NaV1.7 produces a rapidly activating and inactivating [213] and is characterized by slow closed-state inactivation, allowing the channel to produce a substantial ramp current in response to small, slow depolarizations[849]. NaV1.7 is considered to be a threshold channel because of its ability to boost subthreshold stimuli increases the probability of neurons reaching their threshold for firing action potentials. In DRG neurons, Nav1.7 produces resurgent currents triggered by repolarization following a strong depolarization [1419].
Model
References
Herzog RI
et al.
Distinct repriming and closed-state inactivation kinetics of Nav1.6 and Nav1.7 sodium channels in mouse spinal sensory neurons.
J. Physiol. (Lond.),
2003
Sep
15
, 551 (741-50).
Brackenbury WJ
et al.
Nerve growth factor enhances voltage-gated Na+ channel activity and Transwell migration in Mat-LyLu rat prostate cancer cell line.
J. Cell. Physiol.,
2007
Mar
, 210 (602-8).
216
Dib-Hajj SD
et al.
Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable.
,
2008
, 4 (37).
Gould HJ
et al.
A possible role for nerve growth factor in the augmentation of sodium channels in models of chronic pain.
Brain Res.,
2000
Jan
31
, 854 (19-29).
Djouhri L
et al.
Sensory and electrophysiological properties of guinea-pig sensory neurones expressing Nav 1.7 (PN1) Na+ channel alpha subunit protein.
J. Physiol. (Lond.),
2003
Jan
15
, 546 (565-76).
Cummins TR
et al.
Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel.
J. Neurosci.,
1998
Dec
1
, 18 (9607-19).
Catterall WA
From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels.
Neuron,
2000
Apr
, 26 (13-25).
Waxman SG
et al.
Erythermalgia: molecular basis for an inherited pain syndrome.
,
2005
Dec
, 11 (555-62).
Dib-Hajj SD
et al.
The Na(V)1.7 sodium channel: from molecule to man.
Nat. Rev. Neurosci.,
2012
Dec
12
, 14 (49-62).
Dib-Hajj SD
et al.
Sodium channels in normal and pathological pain.
Annu. Rev. Neurosci.,
2010
, 33 (325-47).
Chattopadhyay M
et al.
Continuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathy.
J. Neurosci.,
2008
Jun
25
, 28 (6652-8).
Stamboulian S
et al.
ERK1/2 Mitogen-Activated Protein Kinase Phosphorylates Sodium Channel Nav1.7 and Alters Its Gating Properties.
J. Neurosci.,
2010
Feb
3
, 30 (1637-47).
Toledo-Aral JJ
et al.
Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons.
Proc. Natl. Acad. Sci. U.S.A.,
1997
Feb
18
, 94 (1527-32).
1415
Saleh S
et al.
Electrophysiological and molecular identification of voltage-gated sodium channels in murine vascular myocytes.
J. Physiol. (Lond.),
2005
Oct
1
, 568 (155-69).
Weiss J
et al.
Loss-of-function mutations in sodium channel Nav1.7 cause anosmia.
Nature,
2011
Apr
14
, 472 (186-90).
Waxman SG
Neuroscience: Channelopathies have many faces.
Nature,
2011
Apr
14
, 472 (173-4).
Diss JK
et al.
Expression profiles of voltage-gated Na(+) channel alpha-subunit genes in rat and human prostate cancer cell lines.
Prostate,
2001
Aug
1
, 48 (165-78).
Greenbaum L
et al.
Contribution of genetic variants to pain susceptibility in Parkinson disease.
Eur J Pain,
2012
Oct
, 16 (1243-50).
Shields SD
et al.
Sodium channel Na(v)1.7 is essential for lowering heat pain threshold after burn injury.
J. Neurosci.,
2012
Aug
8
, 32 (10819-32).
Nassar MA
et al.
Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8.
,
2005
, 1 (24).
Nassar MA
et al.
Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain.
Proc. Natl. Acad. Sci. U.S.A.,
2004
Aug
24
, 101 (12706-11).
Ahmad S
et al.
A stop codon mutation in SCN9A causes lack of pain sensation.
Hum. Mol. Genet.,
2007
Sep
1
, 16 (2114-21).
Credits
To cite this page: [Contributors] Channelpedia https://channelpedia.epfl.ch/ionchannels/126/ , accessed on [date]